Pharmaleads' DENKIs are designed to offer healthcare providers and patients an improved pain management option that helps address the opioid epidemic. The company believes that its products can change the lives of many patients who are in need of improved treatment options for their chronic and/or acute pain. Pharmaleads' medicines are based on enkephalins, a key element of the physiological pain modulation system, enabling healthcare institutions and patients suffering from severe chronic and acute pain to avail improved pain relief.